Agilon Health (AGL) Enterprise Value (2020 - 2025)
Agilon Health (AGL) has disclosed Enterprise Value for 6 consecutive years, with -$285.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 28.71% year-over-year to -$285.1 million, compared with a TTM value of -$285.1 million through Dec 2025, up 28.71%, and an annual FY2025 reading of -$285.1 million, up 28.71% over the prior year.
- Enterprise Value was -$285.1 million for Q4 2025 at Agilon Health, down from -$139.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$105.4 million in Q1 2021 and bottomed at -$1.1 billion in Q2 2021.
- Average Enterprise Value over 5 years is -$596.0 million, with a median of -$445.5 million recorded in 2023.
- The sharpest move saw Enterprise Value plummeted 874.15% in 2021, then soared 64.58% in 2025.
- Year by year, Enterprise Value stood at -$1.0 billion in 2021, then rose by 15.62% to -$877.8 million in 2022, then skyrocketed by 44.28% to -$489.2 million in 2023, then increased by 18.23% to -$400.0 million in 2024, then rose by 28.71% to -$285.1 million in 2025.
- Business Quant data shows Enterprise Value for AGL at -$285.1 million in Q4 2025, -$139.2 million in Q3 2025, and -$327.0 million in Q2 2025.